Postinduction video-mediastinoscopy is as accurate and safe as video-mediastinoscopy in patients without pretreatment for potentially operable non-small cell lung cancer

Détails

ID Serval
serval:BIB_311036DDF4BC
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Postinduction video-mediastinoscopy is as accurate and safe as video-mediastinoscopy in patients without pretreatment for potentially operable non-small cell lung cancer
Périodique
Annals of Thoracic Surgery
Auteur(s)
Lardinois  D., Schallberger  A., Betticher  D., Ris  H. B.
ISSN
0003-4975 (Print)
Statut éditorial
Publié
Date de publication
04/2003
Volume
75
Numéro
4
Pages
1102-6
Notes
Comparative Study
Journal Article --- Old url value: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12683545 --- Old month value: Apr
Résumé
BACKGROUND: Prospective assessment of accuracy and safety of video-mediastinoscopy (VMS) in patients without pretreatment and those after induction therapy for potentially operable non-small cell lung cancer. METHODS: Between 1996 and 1999, 219 patients underwent VMS at our institution: 195 patients without pretreatment and 24 after completion of induction therapy. Mediastinal lymph nodes were dissected and biopsied according to the American Thoracic Society (ATS) lymph node mapping system using a video-assisted approach. The accuracy of VMS was assessed for each patient according to the results obtained from mediastinal lymph node dissection (MLND) performed during lung resection. RESULTS: Video-mediastinoscopy in patients without pretreatment revealed a sensitivity, specificity, and accuracy as compared with MLND of 87%, 100%, and 95.6%, respectively, and a procedure-related complication rate of 4% (8/195 patients). Video-mediastinoscopy in patients after induction therapy revealed a sensitivity, specificity, and accuracy of 81%, 100%, and 91% as compared with MLND, without apparent complications. CONCLUSIONS: Video-mediastinoscopy performed after induction therapy for non-small cell lung cancer is as accurate as mediastinoscopy in patients without pretreatment and did not confer additional morbidity.
Mots-clé
Adult Aged Aged, 80 and over Carcinoma, Non-Small-Cell Lung/drug therapy/*pathology/surgery *Chemotherapy, Adjuvant Combined Modality Therapy Female Humans Lung Neoplasms/drug therapy/*pathology/surgery Lymph Node Excision Lymphatic Metastasis/diagnosis Male Mediastinoscopy/*methods Middle Aged Neoplasm Staging/*methods Sensitivity and Specificity *Video Recording
Pubmed
Web of science
Création de la notice
29/01/2008 13:00
Dernière modification de la notice
20/08/2019 13:16
Données d'usage